ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1469

$618K Total Retail Price of All Prescriptions

Rank: 97 out of 1469

565 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
FUROSEMIDE 1,111 1,028 172 1 8
SIMVASTATIN 979 894 138 2 6
METOPROLOL TARTRATE 785 698 113 3 10
AMLODIPINE BESYLATE 712 675 102 4 3
ISOSORBIDE MONONITRATE ER 653 625 88 5 13
METFORMIN HCL 589 501 85 6 25
DIOVAN 574 574 72 7 14
LISINOPRIL 441 368 73 8 7
LOSARTAN POTASSIUM 414 377 70 9 11
ATORVASTATIN CALCIUM 397 357 61 10 1
LEVOTHYROXINE SODIUM 386 381* 56 11 21
WARFARIN SODIUM 368 317 60 12 9
OMEPRAZOLE 346 333 60 13 23
CLOPIDOGREL 290 260 41 14 5
CARVEDILOL 277 236 45 15 2
CLONIDINE HCL 256 235 41 16 43
JANUVIA 234 207 32 17 64
MELOXICAM 220 215* 40 18 76
PANTOPRAZOLE SODIUM 214 209* 38 19 41
IBUPROFEN 214 200 60 19 92
DIGOXIN 212 207* 28 21 51
ATENOLOL 210 205* 31 22 12
KLOR-CON 8 207 207 31 23 73
ENALAPRIL MALEATE 196 166 32 24 52
ALPRAZOLAM 192 175 51 B 25 75
NITROSTAT 163 158* 70 26 30
HYDROCHLOROTHIAZIDE 157 140 30 27 16
TEMAZEPAM 150 150 31 B 28 110
ALENDRONATE SODIUM 150 145* 24 28 50
GABAPENTIN 146 127 32 30 48
CELEBREX 145 140* 22 31 81
GLIPIZIDE 144 125 24 32 72
FAMOTIDINE* 142 137* 24 33 61
ZOLPIDEM TARTRATE 140 135* 38 34 34
HYDRALAZINE HCL 137 122 22 35 36
AMIODARONE HCL 128 123* 23 36 20
PAROXETINE HCL 127 122* 22 37 129
ZETIA 123 123 16 38 27
CRESTOR 122 117* 20 39 15
NEXIUM 116 111* 18 40 47
METOPROLOL SUCCINATE 115 93 16 41 4
DIGOX 111 96 23 42 17
LANTUS 107 102* 16 43 107
GLYBURIDE 105 93 15 R 44 121
PIOGLITAZONE HCL 96 79 12 R 45 88
ACETAMINOPHEN-CODEINE 95 90* 57 S3 46 113
PRAVASTATIN SODIUM 95 90* 12 46 19
VOLTAREN 93 88* 32 48 80
TAMSULOSIN HCL 90 90 18 49 44
MECLIZINE HCL 84 79* 27 50 104
MEGESTROL ACETATE 80 75* 25 R 51 133
FINASTERIDE 80 <11 <11 51 137
ALLOPURINOL 78 73* 13 53 45
POTASSIUM CHLORIDE 71 66* 12 54 18
BUMETANIDE 70 41 13 55 124
AZITHROMYCIN 67 62* 57 56 79
SERTRALINE HCL 65 65 15 57 96
DILTIAZEM HCL 62 <11 <11 58 145
AMOXICILLIN 62 57* 54 58 141
TRAMADOL HCL 60 40 21 60 55
PROAIR HFA 59 54* 16 61 82
SUCRALFATE 57 52* 18 62 205
LOSARTAN-HYDROCHLOROTHIAZIDE 55 <11 <11 63 32
ESCITALOPRAM OXALATE 53 48* 11 64 86
METOLAZONE 50 <11 <11 65 115
LORAZEPAM 50 45* 14 B 65 60
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.